Suppr超能文献

低水平镉暴露与骨质疏松症

Low-level cadmium exposure and osteoporosis.

作者信息

Alfvén T, Elinder C G, Carlsson M D, Grubb A, Hellström L, Persson B, Pettersson C, Spång G, Schütz A, Järup L

机构信息

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

出版信息

J Bone Miner Res. 2000 Aug;15(8):1579-86. doi: 10.1359/jbmr.2000.15.8.1579.

Abstract

Osteoporosis is a major cause of morbidity worldwide. A number of risk factors, such as age and gender, are well established. High cadmium exposure causes renal damage and in severe cases also causes osteoporosis and osteomalacia. We have examined whether long-term low-level cadmium exposure increases the risk of osteoporosis. Bone mineral density (BMD) in the forearm was measured in 520 men and 544 women, aged 16-81 years, environmentally or occupationally exposed to cadmium, using dual-energy X-ray absorptiometry (DXA) technique. Cadmium in urine was used as the dose estimate and protein HC was used as a marker of renal tubular damage. There was a clear dose-response relation between cadmium dose and the prevalence of tubular proteinuria. Inverse relations were found between cadmium dose, tubular proteinuria, and BMD, particularly apparent in persons over 60 years of age. There was a dose-response relation between cadmium dose and osteoporosis. The odds ratios (ORs) for men were 2.2 (95% CI, 1.0-4.8) in the dose group 0.5-3 nmol Cd/mmol creatinine and 5.3 (2.0-14) in the highest dose category (> or = 3 nmol/mmol creatinine) compared with the lowest dose group (< 0.5 nmol Cd/mmol creatinine). For women, the OR was 1.8 (0.65-5.3) in the dose group 0.5-3 nmol Cd/mmol creatinine. We conclude that exposure to low levels of cadmium is associated with an increased risk of osteoporosis.

摘要

骨质疏松症是全球发病的主要原因。一些风险因素,如年龄和性别,已被充分证实。高镉暴露会导致肾脏损伤,严重时还会导致骨质疏松症和骨软化症。我们研究了长期低水平镉暴露是否会增加患骨质疏松症的风险。使用双能X线吸收法(DXA)技术,对520名年龄在16 - 81岁之间、因环境或职业接触镉的男性和544名女性的前臂骨矿物质密度(BMD)进行了测量。尿镉用作剂量估计指标,蛋白HC用作肾小管损伤的标志物。镉剂量与肾小管蛋白尿患病率之间存在明显的剂量反应关系。发现镉剂量、肾小管蛋白尿与BMD之间呈负相关,在60岁以上人群中尤为明显。镉剂量与骨质疏松症之间存在剂量反应关系。与最低剂量组(<0.5 nmol Cd/mmol肌酐)相比,男性在0.5 - 3 nmol Cd/mmol肌酐剂量组的优势比(OR)为2.2(95%CI,1.0 - 4.8),在最高剂量类别(≥3 nmol/mmol肌酐)中的OR为5.3(2.0 - 14)。对于女性,在0.5 - 3 nmol Cd/mmol肌酐剂量组的OR为

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验